Vivace Therapeutics Announces Issuance of New U.S. Composition of Matter Patents
SAN MATEO, Calif.: SAN MATEO, Calif., Feb. 3, 2022 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, today announced that the United States Patent and Trademark Office (USPTO) has issued the company two new composition of matter patents. The...
